UK reagents and therapeutics developer, Aptamer Group has extended its current agreement with global biopharmaceutical company AstraZeneca. This agreement will build upon the existing collaboration to evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of developing next-generation drug delivery vehicles, Optimer-drug conjugates. Optimers… Read More
Contract Research Organisation (CRO) Veramed has joined a community of global companies using business as a force for good. Veramed, provider of specialist statistics and programming services to biopharmaceutical companies, announced that it has been awarded a B Corporation certification. The certification addresses all parts of a business’ operations, covering… Read More
Novaratis has signed an initial agreement to manufacture biopharmaceutical company CureVac’s COVID-19 vaccine candidate, CVnCoV. Following final agreement, Novartis plans to start manufacturing of the mRNA and bulk drug product in the second quarter of 2021. It is anticipated to produce up to 50 million doses by the end of… Read More
Metabolon and Cleveland Clinic have entered into multi-year collaborative agreement to accelerate research, drug development and precision medicine. Metabolon will leverage its proprietary platform to analyse a range of biologic samples to help discover metabolomic biomarkers that will deepen understanding of Cleveland Clinic’s novel discoveries, improve speed of decision-making and… Read More
BioIVT, provider of research models and services for drug and diagnostic development, is supplying peripheral blood mononuclear cells (PBMCs) for Promega’s antibody-dependent Cellular Cytotoxicity (ADCC) bioassay bioassay, which uses PBMCs to mimic in vivo conditions and measure the ADCC of antibodies during drug development and characterisation. “This new platform combines BioIVT’s high… Read More
Clinical pharmatech company Exscientia’s Series C financing round was completed with investment of $30 million from BlackRock, which will accelerate its AI drug discovery platform and pipeline. Blackrock funds joined Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital in the investment $100 million round. New capital will be… Read More
Wellcome Sanger Institute researchers have developed new software to quickly query databases generated from single-cell sequencing. The open access scfind software can be used to identify which cell types are active in any combination of genes, and enables analysis of multiple datasets containing millions of cells by a wide range… Read More
Automation software developers Celltrio and Biosero will integrate Biosero’s Green Button Go Automation Scheduling Software with Celltrio’s RoboCell Automation Platform to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a new end-to-end system. The aim is that Green Button Go will accelerate the cell culture and harvesting… Read More
Interim study results show the effectiveness of one dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines in preventing hospitalisation of people in their 80s with multiple comorbidities. The AvonCAP study results are by researchers from the University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) and North Bristol… Read More
Budget Chancellor Rishi Sunak announced a £5 million investment in CPI to develop an mRNA ‘vaccine library’, as part of the government’s vaccines support package. The vaccine library will form the basis of a rapid response facility, enabling mRNA vaccines to be developed to help protect against new variants of… Read More
Thermo Fisher Scientific has launched the Thermo Scientific Herasafe 2025 BSC, for the safe sample handling needs of life science applications. It is a Class II Biological Safety Cabinet (BSC) designed to meet the sample and user protection requirements of bioprocessing, clinical diagnostic and biopharmaceutical laboratories. According to Thermo Fisher… Read More
Repositive has announced that UK-based personalised therapeutics company Vivan Therapeutics will join its network of cancer model partners. Vivan Therapeutics is a personalised therapeutics company that engineers drosophila ‘avatar’ models for cancer research and development. Its technology engineers the genetic complexity of a cancer patient’s unique tumour network (up to… Read More
IDT, genomics solutions provider, has launched a new system to provide an end-to-end solution for characterising and quantifying the full array of on and off-target genome editing events in CRISPR research projects, and other genome editing projects. The system uses IDT rhAmpSeq technology, which is designed to enable accurate amplicon… Read More
A new survey conducted by SwedenBIO shows that Swedish life science companies are more confident about future growth than they were before COVID-19, with 80% planning for new hires and expansion. The survey shows a major upswing in the industry, following on from similar reports a year ago which demonstrated… Read More
A new UK study by Octave seeks to understand the immune response to COVID-19 vaccinations in patients with certain immunosuppressed conditions, including cancer. Funded by the Medical Research Council (MRC), researchers from the Universities of Glasgow, Birmingham (sponsors), Oxford, Liverpool, Imperial College London and Leeds Teaching Hospitals NHS Trust will… Read More
CN Bio has received a grant from Innovate UK to develop human-relevant single and multi-organ microphysiological systems (MPS) to advance investigations into SARS-CoV-2 infection and advance 3D lung cell culture models to accelerate drug discovery. The grant will be spent developing and testing advanced cell culture models that represent different… Read More
